$4.75
0.112.37%
At close: -
$4.90
0.153.16%
After Hours: Nov 22, 7:30 PM EDT
Comments
Loading...
Latest news for Relay Therapeutics (NASDAQ:RLAY) Stock
Relay Therapeutics Stock (NASDAQ: RLAY)
Categories: All
Friday, November 08, 2024
Wednesday, November 06, 2024
Monday, October 14, 2024
Tuesday, September 17, 2024
Monday, September 16, 2024
Wednesday, September 11, 2024
- Why Relay Therapeutics (RLAY) Stock Is Down 17% Today
- This Novartis Analyst Is No Longer Bullish; Here Are Top Downgrades For Wednesday
- GameStop Reports Weak Sales, Joins Petco, Relay Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Relay Therapeutics shares are trading lower a...
- Why Dave & Buster's Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
- Reported Earlier, Relay Therapeutics Prices $...
Tuesday, September 10, 2024
- Relay Therapeutics Faces Downgrade Over Efficacy Concerns in Competitive PI3K Inhibitor Market
- B of A Securities Maintains Buy on Relay Ther...
- JP Morgan Maintains Overweight on Relay Thera...
- Barclays Maintains Overweight on Relay Therap...
- Relay Therapeutics shares are trading lower a...
- This Johnson Controls International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
- Goldman Sachs Reinstates Buy on Relay Therape...
- Jefferies Upgrades Relay Therapeutics to Buy,...
- Oppenheimer Downgrades Relay Therapeutics to ...
- Dow Jumps Over 1% Following Last Week's Selloff: Investor Sentiment Improves, But Fear & Greed Index Remains In 'Fear' Zone
Monday, September 09, 2024
- Relay Therapeutics Commences Public Offering ...
- Crude Oil Gains Over 1%; Relay Therapeutics Shares Spike Higher
- Nasdaq Surges Over 1%; US Wholesale Inventories Rise 0.2% In July
- Relay Therapeutics Advances Towards Pivotal Trial As It Shares Encouraging Breast Cancer Data In Heavily Pretreated Patients
- Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
- US Stocks Higher; Dow Surges Over 200 Points
- Relay Therapeutics shares are trading higher ...
- Relay Therapeutics Reports Interim Data for B...